Fucoidan(Seaweed) Based Gel Around Osseous Defects
Clinical And Radiographic Evaluation Of Fucoidan Gel In Patients With Osseous Defects- A Case Series
1 other identifier
observational
5
1 country
1
Brief Summary
The current study is a prospective case series study to evaluate the effect of Fucoidan gel around osseous defects to assess the wound healing and bone regeneration
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jun 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 11, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 11, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2026
CompletedFirst Submitted
Initial submission to the registry
August 24, 2026
CompletedFirst Posted
Study publicly available on registry
August 31, 2026
CompletedAugust 31, 2026
August 1, 2026
4 months
August 24, 2026
August 28, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
wound healing following placement of fucoidan gel
Landry, Turnbull and Howley wound healing index
7th day,14th day, 21st day, 1 month, at 3months and 6 months
Secondary Outcomes (1)
crestal bone level
baseline, 3month and 6 month
Study Arms (1)
placement of fucoidan gel in osseous defects
Drug: Fucoidan extracted from F. Vesiculosus placement of fucoidan gel in osseous defects such as intrabony defect, compromised bone support
Eligibility Criteria
All the patients who meet the eligible criteria will undergo Scaling and root planning (SRP) as a part of Phase I therapy. Patients with ≥6mm probing sites will undergo surgical therapy, patients presenting with different osseous defects will be treated with Fucoidan gel. A total of 5 samples will be allotted to different defects
You may qualify if:
- Systemically healthy patients between 25 to 55 years.
- Stage II/III and Grade B periodontitis patient.
- Osseous defects (intra bony defects, compromised bone support and around dental implants)
You may not qualify if:
- Patients with systemic diseases.
- Smokers.
- Patients under anticoagulant therapy.
- Patients under bisphosphonates.
- Pregnant and lactating women
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Krishnadevaraya college of dental sciences and hospital
Bangalore, Karnataka, 562157, India
Study Officials
- STUDY DIRECTOR
DR .Prabhuji MLV, MDS
Krishnadevaraya college of dental sciences and hospital
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 24, 2026
First Posted
August 31, 2026
Study Start
June 11, 2025
Primary Completion
October 11, 2025
Study Completion
June 30, 2026
Last Updated
August 31, 2026
Record last verified: 2026-08